» Articles » PMID: 28667907

Non-alcoholic Fatty Liver Disease, to Struggle with the Strangle: Oxygen Availability in Fatty Livers

Overview
Journal Redox Biol
Date 2017 Jul 2
PMID 28667907
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Nonalcoholic fatty liver diseases (NAFLD) is one of the most common chronic liver disease in Western countries. Oxygen is a central component of the cellular microenvironment, which participate in the regulation of cell survival, differentiation, functions and energy metabolism. Accordingly, sufficient oxygen supply is an important factor for tissue durability, mainly in highly metabolic tissues, such as the liver. Accumulating evidence from the past few decades provides strong support for the existence of interruptions in oxygen availability in fatty livers. This outcome may be the consequence of both, impaired systemic microcirculation and cellular membrane modifications which occur under steatotic conditions. This review summarizes current knowledge regarding the main factors which can affect oxygen supply in fatty liver.

Citing Articles

Quantitative assessment of inflammation and evaluation of spatial heterogeneity for non-alcoholic fatty liver disease in mice based on iron-adjustive T1.

Li L, Liao B, Cai H, Zhang Y, Deng K, Chen Y Quant Imaging Med Surg. 2024; 14(1):219-230.

PMID: 38223091 PMC: 10784091. DOI: 10.21037/qims-23-782.


Evaluation of Trace Elements Levels and Construction of Auxiliary Prediction Model in Patients with Diabetes Ketoacidosis in Type 1 Diabetes.

Chai J, Sun Z, Zhou Q, Xu J Diabetes Metab Syndr Obes. 2023; 16:3403-3415.

PMID: 37929055 PMC: 10624197. DOI: 10.2147/DMSO.S425156.


Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress.

da Silva Pereira E, de Araujo B, Rodrigues K, Silvares R, Martins C, Flores E Nutrients. 2022; 14(3).

PMID: 35277075 PMC: 8838100. DOI: 10.3390/nu14030716.


Gardenoside Hinders Caspase-1-Mediated Hepatocyte Pyroptosis Through the CTCF/DPP4 Signaling Pathway.

Shen T, Lei T, Chen L, Zhu B, Xu B, Zhang C Front Physiol. 2021; 12:669202.

PMID: 34566670 PMC: 8455910. DOI: 10.3389/fphys.2021.669202.


A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models.

Daou N, Viader A, Cokol M, Nitzel A, Chakravarthy M, Afeyan R Sci Rep. 2021; 11(1):11861.

PMID: 34088912 PMC: 8178416. DOI: 10.1038/s41598-021-88913-1.


References
1.
Rosenstengel S, Stoeppeler S, Bahde R, Spiegel H, Palmes D . Type of steatosis influences microcirculation and fibrogenesis in different rat strains. J Invest Surg. 2011; 24(6):273-82. DOI: 10.3109/08941939.2011.586094. View

2.
Brunt E, Janney C, Di Bisceglie A, Neuschwander-Tetri B, Bacon B . Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999; 94(9):2467-74. DOI: 10.1111/j.1572-0241.1999.01377.x. View

3.
Targher G, Day C, Bonora E . Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010; 363(14):1341-50. DOI: 10.1056/NEJMra0912063. View

4.
McPherson D . Circulatory dysfunction in NAFLD--which is first, which is last, and what do we do in between?. Hepatology. 2005; 42(2):270-2. DOI: 10.1002/hep.20834. View

5.
Bogaerts E, Heindryckx F, Devisscher L, Paridaens A, Vandewynckel Y, Van den Bussche A . Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors. PLoS One. 2015; 10(3):e0119555. PMC: 4368520. DOI: 10.1371/journal.pone.0119555. View